A young child has been successfully treated for juvenile myelomonocytic leukaemia (JMML), after genetic analysis of the disease pointed to a drug approved for completely different cancers.
Chemotherapy failed to control the child’s disease, which...
4 years ago
A low-cost drug that has been used for 40 years to treat arthritis could be used for patients with myeloproliferative neoplasms (MPNs), according to a new study.
The research is a retrospective evaluation of 11 MPN patients, led by Dr Martin Zeidl...
4 years ago
